Squarepoint Ops LLC - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 233 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2020. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.

Quarter-by-quarter ownership
Squarepoint Ops LLC ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q2 2022$3,364,000
+28.5%
105,305
+39.3%
0.02%
+72.7%
Q1 2022$2,618,000
+106.0%
75,578
+74.0%
0.01%
+266.7%
Q4 2021$1,271,000
-3.7%
43,430
-16.2%
0.00%
-25.0%
Q3 2021$1,320,000
+182.7%
51,804
+288.6%
0.00%
+100.0%
Q2 2021$467,000
-6.2%
13,332
+9.0%
0.00%
-33.3%
Q1 2021$498,000
-32.4%
12,230
-28.1%
0.00%
-40.0%
Q4 2020$737,000
+114.2%
17,019
+172.4%
0.01%0.0%
Q3 2020$344,000
-88.3%
6,247
-86.6%
0.01%
-89.6%
Q2 2020$2,941,000
+492.9%
46,591
+379.7%
0.05%
+269.2%
Q1 2020$496,000
-66.6%
9,713
-48.0%
0.01%
+44.4%
Q4 2019$1,486,000
-50.4%
18,695
-69.7%
0.01%
-66.7%
Q3 2019$2,996,000
-12.9%
61,746
-5.6%
0.03%
-20.6%
Q2 2019$3,439,000
+210.9%
65,383
+212.8%
0.03%
+183.3%
Q1 2019$1,106,000
+78.1%
20,900
+38.0%
0.01%
+71.4%
Q4 2018$621,000
-39.5%
15,140
-43.9%
0.01%
-41.7%
Q3 2018$1,026,000
-23.8%
27,000
-9.4%
0.01%
-33.3%
Q2 2018$1,347,000
+51.5%
29,800
+62.0%
0.02%
+28.6%
Q1 2018$889,000
-46.1%
18,400
-56.1%
0.01%
-51.7%
Q4 2017$1,649,000
+19.0%
41,894
+11.4%
0.03%
-23.7%
Q1 2017$1,386,000
+216.4%
37,606
+24.0%
0.04%
+111.1%
Q4 2016$438,00030,3300.02%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q4 2020
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 595,473$25,790,0004.19%
Grace Capital 131,549$5,697,0003.60%
Fernwood Investment Management, LLC 201,657$8,734,0003.44%
Fairmount Funds Management LLC 215,000$9,312,0003.33%
Arctis Global LLC 293,700$12,720,0002.74%
Perceptive Advisors 5,674,711$245,771,0002.64%
ArchPoint Investors 217,510$9,420,0002.61%
Alerce Investment Management, L.P. 126,270$5,469,0002.15%
Profit Investment Management, LLC 42,196$1,826,0001.17%
Affinity Asset Advisors, LLC 50,000$2,166,0001.15%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders